{"title":"为放射组学的临床影响铺平道路:实现可重复性和可及性","authors":"Mohamad El-Jammal, Caroline Chung","doi":"10.1158/0008-5472.can-25-2083","DOIUrl":null,"url":null,"abstract":"Radiomics, the extraction of quantitative data from images, holds promise for noninvasively characterizing tumor phenotypes. Tools like LIFEx have improved the accessibility, transparency, and reproducibility of radiomic feature extraction by offering standardized, user-friendly workflows across imaging modalities. Introduction of such a platform that enables consistent and transparent analytics has helped democratize access to the exploration of radiomics and has highlighted other fundamental challenges in radiomics, addressing upstream heterogeneity in image acquisition, reconstruction, and region-of-interest segmentation that impede reproducibility. Differences in these upstream steps can drastically alter radiomic features, even when downstream processing is standardized. We highlight ongoing efforts and fundamental challenges that the community will need to tackle collectively to enable the clinical translation of radiomics. By addressing variability throughout the radiomic pipeline, we can ensure that radiomic features better reflect tumor biology, as well as fulfill their potential as robust, generalizable biomarkers for precision oncology. This article is part of a special series: Driving Cancer Discoveries with Computational Research, Data Science, and Machine Learning/AI. See related article by Nioche and colleagues, Cancer Res 2018;78:4786-89","PeriodicalId":9441,"journal":{"name":"Cancer research","volume":"15 1","pages":""},"PeriodicalIF":16.6000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Paving a Path to Clinical Impact with Radiomics: Enabling Reproducibility and Reach\",\"authors\":\"Mohamad El-Jammal, Caroline Chung\",\"doi\":\"10.1158/0008-5472.can-25-2083\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Radiomics, the extraction of quantitative data from images, holds promise for noninvasively characterizing tumor phenotypes. Tools like LIFEx have improved the accessibility, transparency, and reproducibility of radiomic feature extraction by offering standardized, user-friendly workflows across imaging modalities. Introduction of such a platform that enables consistent and transparent analytics has helped democratize access to the exploration of radiomics and has highlighted other fundamental challenges in radiomics, addressing upstream heterogeneity in image acquisition, reconstruction, and region-of-interest segmentation that impede reproducibility. Differences in these upstream steps can drastically alter radiomic features, even when downstream processing is standardized. We highlight ongoing efforts and fundamental challenges that the community will need to tackle collectively to enable the clinical translation of radiomics. By addressing variability throughout the radiomic pipeline, we can ensure that radiomic features better reflect tumor biology, as well as fulfill their potential as robust, generalizable biomarkers for precision oncology. This article is part of a special series: Driving Cancer Discoveries with Computational Research, Data Science, and Machine Learning/AI. See related article by Nioche and colleagues, Cancer Res 2018;78:4786-89\",\"PeriodicalId\":9441,\"journal\":{\"name\":\"Cancer research\",\"volume\":\"15 1\",\"pages\":\"\"},\"PeriodicalIF\":16.6000,\"publicationDate\":\"2025-07-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1158/0008-5472.can-25-2083\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1158/0008-5472.can-25-2083","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
Paving a Path to Clinical Impact with Radiomics: Enabling Reproducibility and Reach
Radiomics, the extraction of quantitative data from images, holds promise for noninvasively characterizing tumor phenotypes. Tools like LIFEx have improved the accessibility, transparency, and reproducibility of radiomic feature extraction by offering standardized, user-friendly workflows across imaging modalities. Introduction of such a platform that enables consistent and transparent analytics has helped democratize access to the exploration of radiomics and has highlighted other fundamental challenges in radiomics, addressing upstream heterogeneity in image acquisition, reconstruction, and region-of-interest segmentation that impede reproducibility. Differences in these upstream steps can drastically alter radiomic features, even when downstream processing is standardized. We highlight ongoing efforts and fundamental challenges that the community will need to tackle collectively to enable the clinical translation of radiomics. By addressing variability throughout the radiomic pipeline, we can ensure that radiomic features better reflect tumor biology, as well as fulfill their potential as robust, generalizable biomarkers for precision oncology. This article is part of a special series: Driving Cancer Discoveries with Computational Research, Data Science, and Machine Learning/AI. See related article by Nioche and colleagues, Cancer Res 2018;78:4786-89
期刊介绍:
Cancer Research, published by the American Association for Cancer Research (AACR), is a journal that focuses on impactful original studies, reviews, and opinion pieces relevant to the broad cancer research community. Manuscripts that present conceptual or technological advances leading to insights into cancer biology are particularly sought after. The journal also places emphasis on convergence science, which involves bridging multiple distinct areas of cancer research.
With primary subsections including Cancer Biology, Cancer Immunology, Cancer Metabolism and Molecular Mechanisms, Translational Cancer Biology, Cancer Landscapes, and Convergence Science, Cancer Research has a comprehensive scope. It is published twice a month and has one volume per year, with a print ISSN of 0008-5472 and an online ISSN of 1538-7445.
Cancer Research is abstracted and/or indexed in various databases and platforms, including BIOSIS Previews (R) Database, MEDLINE, Current Contents/Life Sciences, Current Contents/Clinical Medicine, Science Citation Index, Scopus, and Web of Science.